Barlow, W.E., R.L. Davis, J.W. Glasser, P.H. Rhodes, R.S. Thompson, J.P. Mullooly, S.B. Black, H.R. Shinefield, J.I. Ward, S.M. Marcy, F. DeStefano, R.T. Chen, V. Immanuel, J.A. Pearson, C.M. Vadheim, V. Rebolledo, D. Christakis, P.J. Benson, N. Lewis, and Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. 2001. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. New England Journal of Medicine 345(9):656-661.
Brighton Collaboration. 2012. Brighton Collaboration. Brighton, United Kingdom: Brighton Collaboration. https://brightoncollaboration.org/public.html (accessed August 5, 2012).
CDC (Centers for Disease Control and Prevention). 2011a. National Immunization Survey. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/nis.htm (accessed June 15, 2012).
CDC. 2011b. Vaccine Safety Datalink (VSD) project. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccinesafety/Activities/VSD.html (accessed June 12, 2012).
CDC. 2011c. Clinical Immunization Safety Assessment (CISA) network. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccinesafety/Activities/cisa.html (accessed November 28, 2012).
CDC. 2012a. 2010 IISAR data participation rates. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/programs/iis/annual-report-IISAR/2010-data.html#child (accessed September 3, 2012).
CDC. 2012b. Meaningful use. Atlanta, GA: Centers for Disease Control and Prevention. http://www.cdc.gov/ehrmeaningfuluse (accessed October 3, 2012).
CDC. 2012c. Progress in immunization information systems—United States, 2010. MMWR Morbidity and Mortality Weekly Reports 61(25):464-467.
CDC and FDA (Food and Drug Administration). 2012. Vaccine Adverse Event Reporting System. Atlanta, GA: Centers for Disease Control and Prevention; Rockville, MD: Food and Drug Administration. http://vaers.hhs.gov/index (accessed June 1, 2012).
Chen, R.T., J.W. Glasser, P.H. Rhodes, R.L. Davis, W.E. Barlow, R.S. Thompson, J.P. Mullooly, S.B. Black, H.R. Shinefield, and C.M. Vadheim. 1997. Vaccine Safety Datalink project: A new tool for improving vaccine safety monitoring in the United States. Pediatrics 99(6):765-773.
Chen, R., F. DeStefano, R. Davis, L. Jackson, R. Thompson, J. Mullooly, S. Black, H. Shinefield, C. Vadheim, and J. Ward. 2000. The Vaccine Safety Datalink: Immunization research in health maintenance organizations in the USA. Bulletin of the World Health Organization 78(2):186-194.
Cortese, M.M., J. LeBlanc, K.E. White, R.C. Jerris, P. Stinchfield, K.L. Preston, J. Meek, L. Odofin, S. Khizer, C.A. Miller, V. Buttery, S. Mijatovic-Rustempasic, J. Lewis, U.D. Parashar, and L.C. Immergluck. 2011. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics 128(6):E1474-E1481.
CPRD (Clincal Practice Research Datalink). 2012. Clinical Practice Research Datalink (CPRD). London, United Kingdom: Medicines and Healthcare Products Regulatory Agency, National Institute for Health Research. http://www.cprd.com/intro.asp (accessed July 2, 2012).
Curlin, G., S. Landry, J. Bernstein, R.L. Gorman, B. Mulach, C.J. Hackett, S. Foster, S.E. Miers, and P. Strickler-Dinglasan. 2011. Integrating safety and efficacy evaluation throughout vaccine research and development. Pediatrics 127(Suppl 1):S9-S15.
Curns, A.T., F. Coffin, J.W. Glasser, R.I. Glass, and U.D. Parashar. 2009. Projected impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015. Journal of Infectious Diseases 200(Suppl 1):S49-S56.